Empagliflozin Sheds Liver Fat in People With and Without T2D Empagliflozin Sheds Liver Fat in People With and Without T2D
Empagliflozin reduced liver fat content in patients with obesity and patients with type 2 diabetes.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Empagliflozin | Endocrinology | Jardiance | Liver | Obesity | Urology & Nephrology